Inovio Pharmaceuticals Inc vs TORM plc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while TORM plc trades at $28.3 (market cap $2.93B). The key difference: TORM plc is far larger — about 37.3× Inovio Pharmaceuticals Inc's market cap, and TORM plc pays a 9.77% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | TRMD | |
|---|---|---|
Market Cap | $78.55M | $2.93B |
Sector | Health | Technology |
52-Week High | $2.87 | $34.87 |
52-Week Low | $0.66 | $18.77 |
Enterprise Value | $49.56M | $3.82B |
Dividend Yield | — | 9.77% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →